| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Organoids | 19 | 2024 | 272 | 4.760 |
Why?
|
| Rotavirus Infections | 18 | 2021 | 348 | 3.590 |
Why?
|
| Intestinal Mucosa | 18 | 2024 | 764 | 2.900 |
Why?
|
| Intestines | 14 | 2024 | 571 | 2.270 |
Why?
|
| Rotavirus | 16 | 2019 | 492 | 1.910 |
Why?
|
| Intestine, Small | 9 | 2024 | 302 | 1.710 |
Why?
|
| Stem Cells | 10 | 2023 | 701 | 1.310 |
Why?
|
| Host-Pathogen Interactions | 5 | 2021 | 252 | 1.110 |
Why?
|
| Gastrointestinal Diseases | 5 | 2021 | 335 | 0.940 |
Why?
|
| Intestinal Diseases | 3 | 2019 | 83 | 0.940 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 267 | 0.920 |
Why?
|
| Intestinal Polyposis | 1 | 2023 | 17 | 0.890 |
Why?
|
| Antigens, Viral | 6 | 2011 | 436 | 0.830 |
Why?
|
| Adult Stem Cells | 2 | 2019 | 53 | 0.770 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1915 | 0.770 |
Why?
|
| Cell Culture Techniques | 6 | 2021 | 287 | 0.700 |
Why?
|
| Virus Replication | 8 | 2024 | 600 | 0.660 |
Why?
|
| Communicable Diseases | 1 | 2021 | 163 | 0.650 |
Why?
|
| Microinjections | 1 | 2018 | 52 | 0.630 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 560 | 0.580 |
Why?
|
| Norovirus | 5 | 2024 | 302 | 0.580 |
Why?
|
| Virion | 3 | 2008 | 149 | 0.580 |
Why?
|
| Microchip Analytical Procedures | 1 | 2017 | 6 | 0.580 |
Why?
|
| Microfluidics | 1 | 2017 | 18 | 0.570 |
Why?
|
| Regeneration | 1 | 2019 | 202 | 0.570 |
Why?
|
| Calcitriol | 5 | 2021 | 80 | 0.560 |
Why?
|
| Viremia | 3 | 2007 | 126 | 0.550 |
Why?
|
| Antibodies, Viral | 8 | 2013 | 1132 | 0.500 |
Why?
|
| Immunoglobulin A | 2 | 2012 | 197 | 0.490 |
Why?
|
| Caliciviridae Infections | 5 | 2024 | 314 | 0.460 |
Why?
|
| B-Lymphocytes | 5 | 2012 | 518 | 0.450 |
Why?
|
| Models, Biological | 5 | 2020 | 1434 | 0.450 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 678 | 0.430 |
Why?
|
| IgA Deficiency | 1 | 2012 | 5 | 0.410 |
Why?
|
| Tissue Engineering | 3 | 2020 | 177 | 0.400 |
Why?
|
| Space Flight | 2 | 2022 | 116 | 0.380 |
Why?
|
| Animals | 31 | 2024 | 33618 | 0.380 |
Why?
|
| Mice | 24 | 2024 | 17430 | 0.380 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 678 | 0.370 |
Why?
|
| Cells, Cultured | 5 | 2021 | 3047 | 0.370 |
Why?
|
| Immunity, Innate | 5 | 2024 | 373 | 0.370 |
Why?
|
| Escherichia coli Infections | 3 | 2021 | 191 | 0.360 |
Why?
|
| Transcriptome | 5 | 2024 | 907 | 0.360 |
Why?
|
| Virus Cultivation | 3 | 2024 | 76 | 0.350 |
Why?
|
| Respiratory Syncytial Virus, Human | 2 | 2024 | 204 | 0.350 |
Why?
|
| Organ Culture Techniques | 4 | 2018 | 155 | 0.330 |
Why?
|
| Telomere | 2 | 2021 | 205 | 0.330 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2024 | 334 | 0.330 |
Why?
|
| Humans | 45 | 2024 | 122633 | 0.320 |
Why?
|
| Bacterial Adhesion | 2 | 2020 | 108 | 0.320 |
Why?
|
| Rotavirus Vaccines | 2 | 2006 | 71 | 0.310 |
Why?
|
| Interferons | 2 | 2020 | 120 | 0.300 |
Why?
|
| Prostatic Neoplasms | 5 | 2001 | 1513 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 6 | 2012 | 1002 | 0.290 |
Why?
|
| Colon | 3 | 2021 | 353 | 0.290 |
Why?
|
| Culture Media | 3 | 2024 | 182 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 7 | 2018 | 4323 | 0.280 |
Why?
|
| Capsid Proteins | 2 | 2005 | 181 | 0.280 |
Why?
|
| RNA, Viral | 2 | 2006 | 540 | 0.270 |
Why?
|
| Diarrhea | 3 | 2021 | 315 | 0.240 |
Why?
|
| Gastroenteritis | 4 | 2024 | 332 | 0.240 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 65 | 0.230 |
Why?
|
| Nutritional Status | 2 | 2012 | 296 | 0.230 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 376 | 0.230 |
Why?
|
| Weightlessness | 1 | 2004 | 45 | 0.220 |
Why?
|
| Viruses | 2 | 2021 | 123 | 0.210 |
Why?
|
| Immunity | 1 | 2004 | 183 | 0.210 |
Why?
|
| Enterocytes | 4 | 2024 | 66 | 0.210 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 11 | 0.200 |
Why?
|
| Serotonin | 1 | 2023 | 222 | 0.200 |
Why?
|
| T-Lymphocytes | 3 | 2011 | 1676 | 0.200 |
Why?
|
| Radiation Protection | 1 | 2022 | 54 | 0.200 |
Why?
|
| Liver | 2 | 2021 | 1725 | 0.200 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 208 | 0.200 |
Why?
|
| Radiation Exposure | 1 | 2022 | 43 | 0.190 |
Why?
|
| Enterohepatic Circulation | 1 | 2021 | 10 | 0.190 |
Why?
|
| Wnt Signaling Pathway | 1 | 2023 | 195 | 0.190 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2021 | 6 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2024 | 900 | 0.190 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2020 | 17 | 0.180 |
Why?
|
| Hydrogels | 1 | 2021 | 77 | 0.180 |
Why?
|
| Cytokines | 2 | 2024 | 1280 | 0.170 |
Why?
|
| Gluconeogenesis | 1 | 2020 | 107 | 0.170 |
Why?
|
| Endometrium | 1 | 2023 | 276 | 0.170 |
Why?
|
| Probiotics | 2 | 2012 | 207 | 0.160 |
Why?
|
| Escherichia coli | 3 | 2021 | 980 | 0.160 |
Why?
|
| Virus Diseases | 2 | 2021 | 280 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 172 | 0.160 |
Why?
|
| Stomach | 1 | 2021 | 271 | 0.160 |
Why?
|
| Ileum | 1 | 2019 | 132 | 0.160 |
Why?
|
| Computers | 1 | 2018 | 66 | 0.150 |
Why?
|
| Uterus | 1 | 2023 | 594 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 181 | 0.150 |
Why?
|
| Virus Physiological Phenomena | 1 | 2018 | 14 | 0.150 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 70 | 0.150 |
Why?
|
| Escherichia coli Proteins | 1 | 2020 | 303 | 0.150 |
Why?
|
| Viral Tropism | 1 | 2018 | 34 | 0.150 |
Why?
|
| Vitamin D | 1 | 1999 | 158 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 1670 | 0.140 |
Why?
|
| Immunity, Mucosal | 2 | 2019 | 83 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 522 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2023 | 2306 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 313 | 0.140 |
Why?
|
| G1 Phase | 1 | 1997 | 67 | 0.140 |
Why?
|
| Tretinoin | 1 | 1997 | 116 | 0.140 |
Why?
|
| Feces | 3 | 2021 | 710 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 647 | 0.130 |
Why?
|
| Apoptosis | 2 | 2000 | 1782 | 0.130 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2017 | 109 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 141 | 0.130 |
Why?
|
| Glucose | 1 | 2020 | 867 | 0.130 |
Why?
|
| Antigens, Differentiation | 1 | 2015 | 63 | 0.130 |
Why?
|
| Bacteria | 1 | 2019 | 483 | 0.130 |
Why?
|
| Species Specificity | 2 | 2006 | 547 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 1063 | 0.120 |
Why?
|
| Prostate | 1 | 1997 | 421 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 1675 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 281 | 0.110 |
Why?
|
| Inflammation | 1 | 2020 | 1398 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2015 | 351 | 0.110 |
Why?
|
| Lymphotoxin-alpha | 1 | 2012 | 8 | 0.110 |
Why?
|
| Female | 12 | 2024 | 65117 | 0.100 |
Why?
|
| Infant | 5 | 2024 | 12272 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2000 | 1872 | 0.100 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 216 | 0.100 |
Why?
|
| Animals, Newborn | 2 | 2012 | 988 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 88 | 0.100 |
Why?
|
| Male | 13 | 2024 | 59714 | 0.100 |
Why?
|
| Phenotype | 1 | 2020 | 4200 | 0.090 |
Why?
|
| Interleukin-18 | 2 | 2021 | 60 | 0.090 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2021 | 92 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 933 | 0.090 |
Why?
|
| Viral Load | 1 | 2012 | 382 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2012 | 3710 | 0.090 |
Why?
|
| Telomerase | 2 | 2021 | 164 | 0.090 |
Why?
|
| Body Weight | 2 | 2012 | 959 | 0.090 |
Why?
|
| Adhesins, Escherichia coli | 2 | 2020 | 19 | 0.080 |
Why?
|
| Cell Division | 3 | 2001 | 778 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2012 | 793 | 0.080 |
Why?
|
| Cell Movement | 1 | 2012 | 831 | 0.080 |
Why?
|
| Calcium | 3 | 2007 | 1096 | 0.080 |
Why?
|
| Gene Expression | 1 | 2012 | 1568 | 0.070 |
Why?
|
| HT29 Cells | 1 | 2007 | 46 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2000 | 611 | 0.070 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2007 | 3 | 0.070 |
Why?
|
| Diarrhea, Infantile | 1 | 2007 | 36 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2018 | 423 | 0.070 |
Why?
|
| Immunoassay | 1 | 2007 | 127 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2746 | 0.070 |
Why?
|
| Toxins, Biological | 1 | 2007 | 70 | 0.070 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2007 | 133 | 0.070 |
Why?
|
| Intussusception | 1 | 2006 | 46 | 0.070 |
Why?
|
| Cell Line | 3 | 2019 | 2774 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2005 | 130 | 0.060 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2007 | 193 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2006 | 291 | 0.060 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 13 | 0.060 |
Why?
|
| Actins | 1 | 2007 | 341 | 0.060 |
Why?
|
| Peyer's Patches | 1 | 2004 | 19 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2007 | 369 | 0.060 |
Why?
|
| Hindlimb Suspension | 1 | 2004 | 11 | 0.060 |
Why?
|
| Child | 4 | 2020 | 24086 | 0.060 |
Why?
|
| Rodent Diseases | 1 | 2003 | 17 | 0.060 |
Why?
|
| Cattle Diseases | 1 | 2003 | 21 | 0.060 |
Why?
|
| Jejunum | 1 | 2024 | 128 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2005 | 670 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2004 | 256 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2002 | 419 | 0.050 |
Why?
|
| Adult | 4 | 2024 | 28881 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 298 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2004 | 180 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 12 | 0.050 |
Why?
|
| Stem Cell Niche | 1 | 2023 | 54 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 695 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2023 | 85 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 39 | 0.050 |
Why?
|
| Cattle | 1 | 2003 | 559 | 0.050 |
Why?
|
| Lymphoid Tissue | 1 | 2002 | 44 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 69 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2001 | 691 | 0.050 |
Why?
|
| Epithelium | 1 | 2023 | 366 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2002 | 210 | 0.050 |
Why?
|
| Ketones | 1 | 2001 | 24 | 0.050 |
Why?
|
| Integrins | 1 | 2002 | 81 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 1242 | 0.050 |
Why?
|
| Laminin | 1 | 2021 | 59 | 0.050 |
Why?
|
| Biphenyl Compounds | 1 | 2001 | 56 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 210 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 669 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2021 | 93 | 0.050 |
Why?
|
| Receptors, Calcitriol | 1 | 2001 | 72 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2020 | 1610 | 0.050 |
Why?
|
| Rats | 3 | 2003 | 3620 | 0.050 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2020 | 5 | 0.050 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2020 | 8 | 0.050 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2020 | 11 | 0.050 |
Why?
|
| Palivizumab | 1 | 2021 | 46 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2021 | 267 | 0.050 |
Why?
|
| Fimbriae, Bacterial | 1 | 2020 | 41 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2020 | 42 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 1293 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 4257 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 231 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 312 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2021 | 123 | 0.040 |
Why?
|
| Estrogens | 1 | 2023 | 507 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2000 | 12 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 113 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 53 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2020 | 190 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2020 | 149 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 381 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 123 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2000 | 113 | 0.040 |
Why?
|
| Enteroendocrine Cells | 1 | 2019 | 18 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 215 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 1999 | 39 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2020 | 172 | 0.040 |
Why?
|
| RANK Ligand | 1 | 2019 | 49 | 0.040 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 113 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 300 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2002 | 478 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 282 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 250 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 1102 | 0.040 |
Why?
|
| Retinoid X Receptors | 1 | 1997 | 33 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2000 | 697 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2000 | 804 | 0.040 |
Why?
|
| Terfenadine | 1 | 2017 | 2 | 0.040 |
Why?
|
| Methylamines | 1 | 2017 | 17 | 0.040 |
Why?
|
| Cholecalciferol | 1 | 2017 | 22 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1997 | 100 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1997 | 240 | 0.030 |
Why?
|
| Bile | 1 | 2016 | 46 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 533 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 347 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 669 | 0.030 |
Why?
|
| Metabolome | 1 | 2017 | 293 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 150 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 191 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 114 | 0.030 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1993 | 12 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2013 | 123 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 1468 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1993 | 88 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2528 | 0.030 |
Why?
|
| Virus Shedding | 1 | 2012 | 79 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2012 | 54 | 0.030 |
Why?
|
| Leukocytes | 1 | 2013 | 206 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 308 | 0.020 |
Why?
|
| Thinness | 1 | 2012 | 67 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1993 | 214 | 0.020 |
Why?
|
| Metagenome | 1 | 2012 | 148 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2024 | 8064 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 370 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 233 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 370 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 661 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1216 | 0.020 |
Why?
|
| Base Sequence | 2 | 2012 | 3093 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1997 | 1267 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2006 | 13794 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 372 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 684 | 0.020 |
Why?
|
| Pregnancy | 1 | 2023 | 7105 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 571 | 0.020 |
Why?
|
| Overweight | 1 | 2012 | 344 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 1584 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2395 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 2047 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2020 | 4503 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1684 | 0.020 |
Why?
|
| Transcription Factors | 1 | 1997 | 2575 | 0.020 |
Why?
|
| Gastrointestinal Transit | 1 | 2006 | 21 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1993 | 2815 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2007 | 381 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2003 | 15916 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 815 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 511 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1683 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6188 | 0.010 |
Why?
|
| Receptors, Collagen | 1 | 2002 | 7 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2002 | 16 | 0.010 |
Why?
|
| Integrin alpha2 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Sialic Acids | 1 | 2002 | 19 | 0.010 |
Why?
|
| Integrin alpha4beta1 | 1 | 2002 | 17 | 0.010 |
Why?
|
| Integrin beta1 | 1 | 2002 | 54 | 0.010 |
Why?
|
| Neuraminidase | 1 | 2002 | 34 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 37 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 159 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 410 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 412 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 1068 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2001 | 876 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 1015 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1993 | 46 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 1209 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 3870 | 0.000 |
Why?
|